Menghang Xia Selected Research

Cytochrome P-450 CYP2B6 (CYP2B6)

1/2022

Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Menghang Xia Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 08/2009
8	Infections 12/2022 - 05/2010
5	Hypoxia (Hypoxemia) 01/2018 - 09/2009
4	COVID-19 05/2022 - 01/2021
4	Inflammation (Inflammations) 01/2022 - 09/2009
3	Cardiotoxicity 01/2022 - 01/2017
3	Zika Virus Infection 01/2021 - 10/2016
3	Chordoma 01/2021 - 01/2013
2	Pain (Aches) 04/2023 - 01/2021
2	Flavivirus Infections 12/2020 - 01/2018
2	Viremia 12/2020 - 08/2017
2	Neuroblastoma 01/2018 - 05/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 04/2012
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 10/2015
2	Colonic Neoplasms (Colon Cancer) 02/2016 - 01/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 05/2010
2	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2016 - 08/2011
2	Breast Neoplasms (Breast Cancer) 06/2014 - 05/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Leukemia 01/2022
1	Blast Crisis (Blast Phase) 01/2022
1	Carcinogenesis 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 12/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Obesity 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016
1	Fibrosarcoma 11/2016
1	Microcephaly 10/2016

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2022 - 08/2009
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2009
3	Ether (Diethyl Ether)IBA 01/2022 - 11/2009
3	NF-kappa B (NF-kB)IBA 01/2022 - 05/2010
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 11/2016
3	LuciferasesIBA 02/2016 - 05/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016 - 11/2009
3	CytokinesIBA 01/2012 - 09/2009
2	Angiotensin-Converting Enzyme 2IBA 12/2022 - 05/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2011
2	CateninsIBA 01/2022 - 12/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 10/2019
2	Caspase 3 (Caspase-3)IBA 10/2016 - 05/2010
2	Investigational DrugsIBA 02/2016 - 07/2013
2	baicaleinIBA 01/2016 - 04/2012
2	Digoxin (Digitek)FDA LinkGeneric 07/2013 - 08/2009
2	Oxygen (Dioxygen)IBA 12/2009 - 11/2009
1	Opioid Analgesics (Opioids)IBA 04/2023
1	ButyrylcholinesteraseIBA 01/2023
1	AcetylcholinesteraseIBA 01/2023
1	Potassium Channels (Potassium Channel)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	nirmatrelvir and ritonavir drug combinationIBA 01/2022
1	Orphan Nuclear ReceptorsIBA 01/2022
1	pyrvinium (Vankin)FDA Link 01/2022
1	Antimalarials (Antimalarial Agents)IBA 01/2022
1	sotrovimabIBA 01/2022
1	molnupiravirIBA 01/2022
1	baricitinibIBA 01/2022
1	ERRalpha Estrogen-Related ReceptorIBA 01/2022
1	remdesivirIBA 01/2022
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2021
1	PlatinumIBA 12/2021
1	Opioid Receptors (Opioid Receptor)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2021
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	CrizotinibIBA 01/2021
1	AfatinibIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Methylene Blue (Methylthioninium Chloride)FDA Link 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	Antiviral Agents (Antivirals)IBA 12/2020
1	AMP-Activated Protein KinasesIBA 12/2019
1	ProdrugsIBA 10/2019
1	Erythrosine (Erythrosin)IBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	EmetineIBA 01/2018
1	EnzymesIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	1-dodecylpyridoxal (PLD)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Food Additives (Food Additive)IBA 01/2018
1	cephaelinIBA 01/2018
1	ifenprodilIBA 01/2018
1	temoporfinIBA 08/2017
1	Amplex RedIBA 05/2017
1	PotassiumIBA 01/2017
1	Kelch-Like ECH-Associated Protein 1IBA 11/2016
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 02/2016
1	trametinibIBA 02/2016
1	Niclosamide FDA Link 02/2016
1	Mitogen-Activated Protein KinasesIBA 02/2016
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 02/2016

Therapy/Procedure

15	Therapeutics 01/2023 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2013